Cours RLS Global AB (publ) Nasdaq Stockholm
Actions
SE0005190725
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+33,06 % | 700 Md | |
-4,82 % | 358 Md | |
+19,57 % | 330 Md | |
+3,64 % | 287 Md | |
+16,09 % | 236 Md | |
+6,72 % | 202 Md | |
-9,08 % | 197 Md | |
+4,54 % | 161 Md | |
-3,44 % | 157 Md |